Jamie Elvidge

563 total citations
25 papers, 252 citations indexed

About

Jamie Elvidge is a scholar working on Economics and Econometrics, General Health Professions and Molecular Biology. According to data from OpenAlex, Jamie Elvidge has authored 25 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Economics and Econometrics, 5 papers in General Health Professions and 3 papers in Molecular Biology. Recurrent topics in Jamie Elvidge's work include Health Systems, Economic Evaluations, Quality of Life (17 papers), Pharmaceutical Economics and Policy (7 papers) and Healthcare cost, quality, practices (5 papers). Jamie Elvidge is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (17 papers), Pharmaceutical Economics and Policy (7 papers) and Healthcare cost, quality, practices (5 papers). Jamie Elvidge collaborates with scholars based in United Kingdom, Egypt and Netherlands. Jamie Elvidge's co-authors include Dalia Dawoud, Linda Davies, Gemma Shields, Ash Bullement, Páll Jónsson, Anthony J. Hatswell, Linxuan Zhang, Jonathan Pearson‐Stuttard, Thomas R. Porter and Dawn Lee and has published in prestigious journals such as Blood, PLoS ONE and Journal of Affective Disorders.

In The Last Decade

Jamie Elvidge

24 papers receiving 245 citations

Peers

Jamie Elvidge
Ali A. Nasrallah Lebanon
Michelle B Leavy United States
Laura Dormer United States
Jules T. Mitchel United States
Pierre Elias United States
Antonio Oliva Italy
Ellen M. Werner United States
Benjamin Gregory Carlisle Canada
Rachel Wong United States
Clive Stringer United Kingdom
Ali A. Nasrallah Lebanon
Jamie Elvidge
Citations per year, relative to Jamie Elvidge Jamie Elvidge (= 1×) peers Ali A. Nasrallah

Countries citing papers authored by Jamie Elvidge

Since Specialization
Citations

This map shows the geographic impact of Jamie Elvidge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamie Elvidge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamie Elvidge more than expected).

Fields of papers citing papers by Jamie Elvidge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamie Elvidge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamie Elvidge. The network helps show where Jamie Elvidge may publish in the future.

Co-authorship network of co-authors of Jamie Elvidge

This figure shows the co-authorship network connecting the top 25 collaborators of Jamie Elvidge. A scholar is included among the top collaborators of Jamie Elvidge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamie Elvidge. Jamie Elvidge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Elvidge, Jamie, Diana Delnoij, Saskia Knies, et al.. (2024). Implementing a sandbox approach in health technology assessment: benefits and recommendations. International Journal of Technology Assessment in Health Care. 40(1). e44–e44. 3 indexed citations
3.
Elvidge, Jamie, et al.. (2024). Advancing the use of real world evidence in health technology assessment: insights from a multi-stakeholder workshop. Frontiers in Pharmacology. 14. 1289365–1289365. 9 indexed citations
4.
Shah, Koonal, Jamie Elvidge, & J. Kenny. (2024). HTA39 Using Environmental Impact Data to Support Health Technology Assessment at NICE: An Options Appraisal. Value in Health. 27(12). S360–S361.
5.
Elvidge, Jamie, Tuba Saygın Avşar, Antal Zemplényi, et al.. (2024). Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI). Value in Health. 27(9). 1196–1205. 17 indexed citations
6.
Thokala, Praveen, Robert Smith, Shijie Ren, et al.. (2023). Living Health Technology Assessment: Issues, Challenges and Opportunities. PharmacoEconomics. 41(3). 227–237. 19 indexed citations
7.
Elvidge, Jamie, Saskia Knies, Bertalan Németh, et al.. (2023). Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations. International Journal of Technology Assessment in Health Care. 39(1). e24–e24. 4 indexed citations
8.
Elvidge, Jamie, et al.. (2023). Diagnostics and treatments of COVID-19: two-year update to a living systematic review of economic evaluations. Frontiers in Pharmacology. 14. 1291164–1291164. 1 indexed citations
9.
10.
Sarri, Grammati, Anna Forsythe, Jamie Elvidge, & Dalia Dawoud. (2023). Living health technology assessments: how close to living reality?. BMJ evidence-based medicine. 28(6). 369–371. 5 indexed citations
11.
Pearson‐Stuttard, Jonathan, Rebecca Sloan, Linxuan Zhang, et al.. (2022). Variations in comorbidity burden in people with type 2 diabetes over disease duration: A population-based analysis of real world evidence. EClinicalMedicine. 52. 101584–101584. 43 indexed citations
12.
Németh, Bertalan, Rick A. Vreman, Dalia Dawoud, et al.. (2022). Outcome-based reimbursement in Central-Eastern Europe and Middle-East. Frontiers in Medicine. 9. 940886–940886. 13 indexed citations
13.
Elvidge, Jamie, et al.. (2022). A Review of Economic Models Submitted to NICE’s Technology Appraisal Programme, for Treatments of T1DM & T2DM. Frontiers in Pharmacology. 13. 887298–887298. 4 indexed citations
14.
Elvidge, Jamie, et al.. (2022). Diagnostics and Treatments of COVID-19: A Living Systematic Review of Economic Evaluations. Value in Health. 25(5). 773–784. 13 indexed citations
15.
Shields, Gemma, Becky Pennington, Ash Bullement, Stuart Wright, & Jamie Elvidge. (2021). Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time. PharmacoEconomics. 40(3). 249–256. 3 indexed citations
16.
Elvidge, Jamie & Dalia Dawoud. (2021). Assessing Technologies for COVID-19: What are the Challenges for Health Technology Assessment Agencies? Findings From a Survey and Roundtable Workshop. PharmacoEconomics. 39(12). 1455–1463. 7 indexed citations
17.
Shields, Gemma, Deborah Buck, Jamie Elvidge, Karen P. Hayhurst, & Linda Davies. (2019). Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic Review. International Journal of Technology Assessment in Health Care. 35(4). 317–326. 15 indexed citations
18.
Shields, Gemma, Jamie Elvidge, & Linda Davies. (2017). A systematic review of economic evaluations of seasonal influenza vaccination for the elderly population in the European Union. BMJ Open. 7(6). e014847–e014847. 20 indexed citations
19.
Elvidge, Jamie, Ash Bullement, & Anthony J. Hatswell. (2016). Cost Effectiveness of Characterised Chondrocyte Implantation for Treatment of Cartilage Defects of the Knee in the UK. PharmacoEconomics. 34(11). 1145–1159. 14 indexed citations
20.
Gooding, Sarah, I‐Jun Lau, Pamela Roberts, et al.. (2015). Double Relapsed and/or Refractory Multiple Myeloma: Clinical Outcomes and Real World Healthcare Costs. PLoS ONE. 10(9). e0136207–e0136207. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ali A. Nasrallah Breakdown of academic impact, for papers by Michelle B Leavy Breakdown of academic impact, for papers by Laura Dormer Breakdown of academic impact, for papers by Jules T. Mitchel Breakdown of academic impact, for papers by Pierre Elias Breakdown of academic impact, for papers by Antonio Oliva Breakdown of academic impact, for papers by Ellen M. Werner Breakdown of academic impact, for papers by Benjamin Gregory Carlisle Breakdown of academic impact, for papers by Rachel Wong Breakdown of academic impact, for papers by Clive Stringer
Rankless by CCL
2026